Nalbuphine and Oxycodone Interaction

Drug interaction information between Nalbuphine and Oxycodone.

Nalbuphine and Oxycodone have a documented moderate interaction in FDA labeling.

FDA drug labeling documents a moderate-severity interaction between Nalbuphine and Oxycodone. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Nalbuphine

Opioid Agonist-Antagonist

Drug B

Oxycodone

Opioid Analgesic

How They Interact

Combining these medications can lead to a dangerous increase in breathing problems and muscle weakness.

FDA Label Information

Intervention: Avoid concomitant use Examples: Butorphanol, nalbuphine, pentazocine, buprenorphine Muscle Relaxants Clinical Impact: Oxycodone may enhance the neuromuscular blocking action of skeletal muscle relaxants and produce an increased degree of respiratory depression.

Oxycodone Also Interacts With

View all Oxycodone interactions →

Frequently Asked Questions

What SPL severity band is on file for Nalbuphine + Oxycodone?

Compiled FDA labeling labels this pair moderate. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Oxycodone has 28 labeled pairs on file vs Nalbuphine's 19. In the moderate band specifically: Nalbuphine has 1; Oxycodone has 6 (also Carbamazepine, Rifampin, Buprenorphine, Butorphanol).

What mechanism field is on file for Nalbuphine and Oxycodone?

Combining these medications can lead to a dangerous increase in breathing problems and muscle weakness.

Oxycodone's labeled portfolio outnumbers Nalbuphine

SPL source-record counts only. This page's band is moderate · classes on file: Nalbuphine (Opioid Agonist-Antagonist); Oxycodone (Opioid Analgesic).

Nalbuphine

0 major · 1 moderate · 18 minor · 19 total

Nalbuphine has no other moderate-band peer in this dataset besides Oxycodone.

Oxycodone

0 major · 6 moderate · 22 minor · 28 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.